UBE2N and acute myeloid leukemia: The objective of this approach is to identify targets of UBE2N, which would exhibit decreased ubiquitination and expression upon UBE2N suppression (either through knockdown or inhibition), but could restore leukemic cell function when overexpressed in UBE2Ni-treated AML cells (Figure 3J).